Effect of hysteroscopy before starting in-vitro fertilization for women with recurrent implantation failure

Abstract

Objective: To study if hysteroscopy (HSC) before starting an in-vitro fertilization (IVF) cycle improves IVF outcomes in women with recurrent implantation failure (RIF). Methods: The Medline, Cochrane, EMBASE, and Google Scholar databases were searched using the following keywords until March 31, 2017: in-vitro fertilization; infertility; hysteroscopy; recurrence; embryo implantation; and pregnancy. Randomized controlled trials (RCTs), two-arm prospective studies, and retrospective studies were included. Results: Three RCTs, 3 nonrandomized prospective studies, and 2 retrospective cohort studies were included. The eligible studies included 3932 women with RIF: 1841 in the HSC group and 2091 in the control group. The clinical pregnancy rate and implantation rate was significantly higher in the HSC group compared with the control group (for clinical pregnancy rate, pooled odds ratio [OR]\u200a=\u200a1.64, 95% confidence intervals [CI]: 1.30–2.07, P\u200a<\u200a0.001; for implantation rate, pooled OR\u200a=\u200a1.22, 95% CI: 1.02–1.45, P\u200a=\u200a0.025). The live birth rate (pooled OR\u200a=\u200a1.30, 95% CI: 0.90–1.88, P\u200a=\u200a0.168) and the miscarriage rate (pooled OR\u200a=\u200a0.94, 95% CI: 0.66–1.35, P\u200a=\u200a0.744) of the 2 groups were not statistically significantly. Conclusions: HSC improved the implantation rate and clinical pregnancy rates, but failed to improve live birth rate and did not affect the miscarriage rate in women with RIF undergoing IVF. Since HSC plays a significant role in pregnancy and birth outcomes of women with RIF, further studies are warranted.